Prot #INS1009-202: A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension

Project: Research project

Project Details

StatusActive
Effective start/end date4/1/22 → 4/1/25

Funding

  • PPD Development (Prot #INS1009-202)
  • Insmed Incorporated (Prot #INS1009-202)